Fire Brigade Of Paris Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2016
NCT02736812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Fire Brigade Of Paris Emergency Medicine Dept

Active Ingredients

Drugs in Phase 3 Trials (2)

blood plasma (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blood Coagulation Disorders (Phase 3)

Hemostatic Disorders (Phase 3)

Shock (Phase 3)

Shock, Hemorrhagic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2